Genome-wide association studies with metabolomics

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Disturbances in metabolism are at the root of a variety of human afflictions and complex diseases. Although many of the genes that contribute to these conditions have been identified since the completion of the human genome by genome-wide association studies, it is still unclear for many of these genetic variants how they disrupt cellular processes. In this chapter we shall present the concept of genome-wide association studies with metabolomics. These studies show how combining two highly sophisticated biochemical measurement methods, genetics and metabolomics, applied to only a small amount of blood, can reveal deep insights into the genetic makeup of the human body's metabolic capacities. In addition to providing functional insights into the genetic basis of metabolic traits and complex diseases, study of what we call genetically determined metabotypes is a way to understand an individual's uniqueness. These genetically determined metabotypes may modify the risk of an individual to develop a disease, the response to medication and therapy, and the reaction to environmental challenges and thereby help to develop highly targeted, personalized therapies and enable novel types of treatments or prevent adverse drug reactions.

Original languageEnglish
Title of host publicationGenetics Meets Metabolomics: From Experiment to Systems Biology
PublisherSpringer New York
Pages265-279
Number of pages15
Volume9781461416890
ISBN (Electronic)9781461416890
ISBN (Print)1461416884, 9781461416883
DOIs
Publication statusPublished - 1 Jul 2012
Externally publishedYes

Fingerprint

Metabolomics
Genome-Wide Association Study
Genes
Human Genome
Drug-Related Side Effects and Adverse Reactions
Human Body
Metabolism
Blood
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Suhre, K. (2012). Genome-wide association studies with metabolomics. In Genetics Meets Metabolomics: From Experiment to Systems Biology (Vol. 9781461416890, pp. 265-279). Springer New York. https://doi.org/10.1007/978-1-4614-1689-0_16

Genome-wide association studies with metabolomics. / Suhre, Karsten.

Genetics Meets Metabolomics: From Experiment to Systems Biology. Vol. 9781461416890 Springer New York, 2012. p. 265-279.

Research output: Chapter in Book/Report/Conference proceedingChapter

Suhre, K 2012, Genome-wide association studies with metabolomics. in Genetics Meets Metabolomics: From Experiment to Systems Biology. vol. 9781461416890, Springer New York, pp. 265-279. https://doi.org/10.1007/978-1-4614-1689-0_16
Suhre K. Genome-wide association studies with metabolomics. In Genetics Meets Metabolomics: From Experiment to Systems Biology. Vol. 9781461416890. Springer New York. 2012. p. 265-279 https://doi.org/10.1007/978-1-4614-1689-0_16
Suhre, Karsten. / Genome-wide association studies with metabolomics. Genetics Meets Metabolomics: From Experiment to Systems Biology. Vol. 9781461416890 Springer New York, 2012. pp. 265-279
@inbook{faa1c662fed54ea7affdc39923cdbc0c,
title = "Genome-wide association studies with metabolomics",
abstract = "Disturbances in metabolism are at the root of a variety of human afflictions and complex diseases. Although many of the genes that contribute to these conditions have been identified since the completion of the human genome by genome-wide association studies, it is still unclear for many of these genetic variants how they disrupt cellular processes. In this chapter we shall present the concept of genome-wide association studies with metabolomics. These studies show how combining two highly sophisticated biochemical measurement methods, genetics and metabolomics, applied to only a small amount of blood, can reveal deep insights into the genetic makeup of the human body's metabolic capacities. In addition to providing functional insights into the genetic basis of metabolic traits and complex diseases, study of what we call genetically determined metabotypes is a way to understand an individual's uniqueness. These genetically determined metabotypes may modify the risk of an individual to develop a disease, the response to medication and therapy, and the reaction to environmental challenges and thereby help to develop highly targeted, personalized therapies and enable novel types of treatments or prevent adverse drug reactions.",
author = "Karsten Suhre",
year = "2012",
month = "7",
day = "1",
doi = "10.1007/978-1-4614-1689-0_16",
language = "English",
isbn = "1461416884",
volume = "9781461416890",
pages = "265--279",
booktitle = "Genetics Meets Metabolomics: From Experiment to Systems Biology",
publisher = "Springer New York",

}

TY - CHAP

T1 - Genome-wide association studies with metabolomics

AU - Suhre, Karsten

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Disturbances in metabolism are at the root of a variety of human afflictions and complex diseases. Although many of the genes that contribute to these conditions have been identified since the completion of the human genome by genome-wide association studies, it is still unclear for many of these genetic variants how they disrupt cellular processes. In this chapter we shall present the concept of genome-wide association studies with metabolomics. These studies show how combining two highly sophisticated biochemical measurement methods, genetics and metabolomics, applied to only a small amount of blood, can reveal deep insights into the genetic makeup of the human body's metabolic capacities. In addition to providing functional insights into the genetic basis of metabolic traits and complex diseases, study of what we call genetically determined metabotypes is a way to understand an individual's uniqueness. These genetically determined metabotypes may modify the risk of an individual to develop a disease, the response to medication and therapy, and the reaction to environmental challenges and thereby help to develop highly targeted, personalized therapies and enable novel types of treatments or prevent adverse drug reactions.

AB - Disturbances in metabolism are at the root of a variety of human afflictions and complex diseases. Although many of the genes that contribute to these conditions have been identified since the completion of the human genome by genome-wide association studies, it is still unclear for many of these genetic variants how they disrupt cellular processes. In this chapter we shall present the concept of genome-wide association studies with metabolomics. These studies show how combining two highly sophisticated biochemical measurement methods, genetics and metabolomics, applied to only a small amount of blood, can reveal deep insights into the genetic makeup of the human body's metabolic capacities. In addition to providing functional insights into the genetic basis of metabolic traits and complex diseases, study of what we call genetically determined metabotypes is a way to understand an individual's uniqueness. These genetically determined metabotypes may modify the risk of an individual to develop a disease, the response to medication and therapy, and the reaction to environmental challenges and thereby help to develop highly targeted, personalized therapies and enable novel types of treatments or prevent adverse drug reactions.

UR - http://www.scopus.com/inward/record.url?scp=84885818842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885818842&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1689-0_16

DO - 10.1007/978-1-4614-1689-0_16

M3 - Chapter

AN - SCOPUS:84885818842

SN - 1461416884

SN - 9781461416883

VL - 9781461416890

SP - 265

EP - 279

BT - Genetics Meets Metabolomics: From Experiment to Systems Biology

PB - Springer New York

ER -